Resumo

MILLAN PEREZ, Sonia Patricia; FONTANILLA DIAZ, Luis Alejandro  e  MARENTES CUBILLOS, Alba Lucía. Recommendations for the treatment of patients with neuromuscular disorders in the context of the COVID-19 pandemic. Acta Neurol Colomb. [online]. 2020, vol.36, n.2, suppl.1, pp.47-53.  Epub 13-Maio-2021. ISSN 0120-8748.  https://doi.org/10.22379/24224022293.

Neuromuscular disorders constitute a heterogeneous group of chronic, genetic or immunological disorders that affect all age groups. Many of the affected patients have muscle weakness, respiratory and cardiovascular disorders, and some of them require the use of immunosuppressive drugs or infusion therapies in the hospital setting.

Currently, the world is facing the pandemic caused by Coronavirus Disease 2019, (Coronavirus Disease 2019, COVID-19), which is the entity caused by infection by the severe respiratory acute syndrome 2, SARS-CoV-2). In this pathology, factors of poor prognosis have been described, among which are age over 60 years, comorbidities such as diabetes mellitus, lung disease, cardiovascular disease, high blood pressure, cancer and immunosuppression.

Taking into account the aforementioned, the need arises to establish general recommendations for the care of patients with neuromuscular pathologies during the pandemic, based on the available literature that allows initial orientation in the management of patients.

Palavras-chave : COVID-19; Neuromuscular Disorders; SARS-CoV-2; Neurophysiology (MeSH).

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )